Aerosol amphotericin B for prevention of invasive pulmonary aspergillosis.
AUTOR(ES)
Beyer, J
RESUMO
The pharmacokinetics and applicability of aerosol amphotericin B administrations were studied in 40 neutropenic patients and 4 healthy volunteers. Particle size was measured and pulmonary deposition was demonstrated by radioisotope studies. Inhalations were easy to administer and were well tolerated, with minimal systemic absorption of the drug.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=187968Documentos Relacionados
- Aerosol amphotericin B is effective for prophylaxis and therapy in a rat model of pulmonary aspergillosis.
- Efficacy of prophylactic aerosol amphotericin B lipid complex in a rat model of pulmonary aspergillosis.
- Bronchoscopy findings in invasive pulmonary aspergillosis.
- Trial of ketoconazole in non-invasive pulmonary aspergillosis.
- Dose-dependent antifungal activity and nephrotoxicity of amphotericin B colloidal dispersion in experimental pulmonary aspergillosis.
